0.4269

20.56% 0.0728

After Hours: .40 -0.0269 -6.30%

IGC Pharma Inc (IGC)

Overview News Price History Option Chain Discussions Forecast Stock Split

IGC Pharma Inc stock is traded at $0.4269, with a volume of 5.85M. It is up +20.56% in the last 24 hours and up +18.72% over the past month. India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.

Previous Close:

$0.3541

Open:

$0.382

24h Volume:

5.85M

Relative Volume:

16.38

Market Cap:

$23.66M

Revenue:

$1.22M

Net Income/Loss:

$-14.15M

P/E Ratio:

-2.0329

EPS:

-0.21

Net Cash Flow:

$-6.55M

1W Performance:

+24.39%

1M Performance:

+18.72%

6M Performance:

+6.72%

1Y Performance:

+18.81%

1-Day Range:

$0.38

$0.48

1-Week Range:

$0.335

$0.48

52-Week Range:

$0.2501

$0.9099

IGC Pharma Inc Stock (IGC) Company Profile

Name

IGC Pharma Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

301-983-0998

Address

4336 Montgomery Avenue, Bethesda, MD

Employee

Twitter

@IGCIR

Next Earnings Date

2024-08-12

Latest SEC Filings

IGC's Discussions on Twitter

IGC Pharma Inc Stock (IGC) Latest News

04:53 AM

IGC Pharma Inc’s latest rating changes from various analysts - Knox Daily

04:53 AM

04:00 AM

IGC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

04:00 AM

02:08 AM

Is IGC Pharma Inc (AMEX:IGC) stock a better investment at this time? - US Post News

02:08 AM

10:50 AM

AvePoint Inc’s latest rating changes from various analysts - Knox Daily

10:50 AM

07:04 AM

IGC Pharma Inc (AMEX: IGC) Down -0.99% This Year: What Is Going To Happen Next - Stocks Register

07:04 AM

Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com Australia

Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock By Investing.com - Investing.com South Africa

Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com India

Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com

Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com UK

Sep 27, 2024

Sep 24, 2024

Ipca Labs shares hit lifetime high after Nomura raises target price - Business Standard

Sep 24, 2024

IPCA Labs shares hit fresh 52-week high as Nomura upgrades target price on strong growth plans - Moneycontrol

Sep 24, 2024

Ipca Labs Shares Hit Life High As Nomura Hikes Target Price - NDTV Profit

Sep 24, 2024

Sep 23, 2024

Nomura expects IPCA Labs shares to rally over 20% from current price, retains Buy call - Business Upturn

Sep 23, 2024

EC approves Iqirvo plus UDCA to treat primary biliary cholangitis - World Pharmaceutical Frontiers

Sep 23, 2024

IPCA Laboratories Looking to Consolidate US Generics Business; Shares Gain - EquityPandit

Sep 23, 2024

Ipca Laboratories to Consolidate US Generics Business; Shares Up 1% - Indiainfoline

Sep 23, 2024

Ratio Revelations: IGC Pharma Inc (IGC)’s Financial Metrics in the Spotlight - The Dwinnex

Sep 19, 2024

IGC-AD1 shows promise in Alzheimer's tau pathology treatment By Investing.com - Investing.com Canada

Sep 19, 2024

Short Interest in ICL Group Ltd (NYSE:ICL) Declines By 6.3% - MarketBeat

Sep 19, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Down 4.1% on Insider Selling - Defense World

Sep 19, 2024

Sep 18, 2024

ICL Group (NYSE:ICL) Shares Gap Down to $4.19 - Defense World

Sep 18, 2024

IGC-AD1 shows promise in Alzheimer's tau pathology treatment By Investing.com - Investing.com Australia

Sep 18, 2024

IGC-AD1 shows promise in Alzheimer's tau pathology treatment - Investing.com

Sep 18, 2024

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment - Business Wire

Sep 18, 2024

Sep 04, 2024

The Daily Hit: September 4, 2024 - Green Market Report

Sep 04, 2024

IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate - Green Market Report

Sep 04, 2024

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease - Yahoo Finance

Sep 04, 2024

IGC Pharma (NYSEMKT:IGC) Given New $3.75 Price Target at Ascendiant Capital Markets - Defense World

Sep 04, 2024

FTC Solar, Inc. (NASDAQ:FTCI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Sep 04, 2024

Sep 03, 2024

The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts - Benzinga

Sep 03, 2024

Aug 27, 2024

The 7 Best Stocks Under 50 Cents To Buy For September 2024! - The Stock Dork

Aug 27, 2024

Aug 26, 2024

IGC Announces Results of its 2024 Annual Stockholders Meeting - Business Wire

Aug 26, 2024

Aug 23, 2024